Verve Therapeutics Inc (VERV)
6.74
-0.40
(-5.54%)
USD |
NASDAQ |
Apr 17, 16:00
6.74
0.00 (0.00%)
After-Hours: 20:00
Verve Therapeutics Total Liabilities (Quarterly): 153.19M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 153.19M |
| September 30, 2023 | 152.04M |
| June 30, 2023 | 123.91M |
| March 31, 2023 | 124.90M |
| December 31, 2022 | 128.29M |
| September 30, 2022 | 125.41M |
| June 30, 2022 | 27.93M |
| Date | Value |
|---|---|
| March 31, 2022 | 17.85M |
| December 31, 2021 | 26.77M |
| September 30, 2021 | 25.94M |
| June 30, 2021 | 21.12M |
| March 31, 2021 | 234.60M |
| December 31, 2020 | 142.32M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
17.85M
Minimum
Mar 2022
234.60M
Maximum
Mar 2021
100.33M
Average
124.90M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
| Acorda Therapeutics Inc | 266.48M |
| Eli Lilly and Co | 53.14B |
| Intellia Therapeutics Inc | 250.81M |
| Beam Therapeutics Inc | 478.38M |
| Editas Medicine Inc | 150.06M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 752.69M |
| Shareholders Equity (Quarterly) | 599.50M |
| Current Ratio | 17.24 |